Connection
Ana Fernandez-Bustamante to Cholinesterase Inhibitors
This is a "connection" page, showing publications Ana Fernandez-Bustamante has written about Cholinesterase Inhibitors.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.413 |
|
|
|
-
Stewart E, Kaizer A, Fioravanti J, Russell N, Hendrickse A, Adams M, Pshak T, Fernandez-Bustamante A. Postoperative residual neuromuscular blockade and hypoventilation after rocuronium and sugammadex or neostigmine for kidney transplantation: A randomized clinical trial. J Clin Anesth. 2026 Apr; 111:112174.
Score: 0.235
-
Stair C, Fernandez-Bustamante A. Sugammadex, the first selective relaxant binding agent for neuromuscular block reversal. Drugs Today (Barc). 2012 Jun; 48(6):405-13.
Score: 0.090
-
Bartels K, Fernandez-Bustamante A, Vidal Melo MF. Reversal of neuromuscular block: what are the costs? Br J Anaesth. 2023 08; 131(2):202-204.
Score: 0.048
-
Krause M, McWilliams SK, Bullard KJ, Mayes LM, Jameson LC, Mikulich-Gilbertson SK, Fernandez-Bustamante A, Bartels K. Neostigmine Versus Sugammadex for Reversal of Neuromuscular Blockade and Effects on Reintubation for Respiratory Failure or Newly Initiated Noninvasive Ventilation: An Interrupted Time Series Design. Anesth Analg. 2020 07; 131(1):141-151.
Score: 0.040